In previous literatures, PYGB have been reported to be upregulated in ovarian cancer and hepatocellular carcinoma, and this dysregulation promotes ovarian cancer cell and hepatocellular carcinoma cell proliferation, invasion, migration and drug resistance (18, 36). This evidence concerns the gene PYGB and hepatocellular carcinoma.